| of miR377 | Test value | P-value | Sig. | ||||||||||
Median (IQR) | Range | |||||||||||||
Diabetic nephropathy stage 1, 2 (group I) | 55.87 (13.31 - 576.53) | 3.05 - 102,658 | 10.774 | 0.029 | S | |||||||||
Diabetic nephropathy stage 3, 4 (group II) | 1.59 (0.15 - 8.17) | 0.04 - 20.97 | ||||||||||||
Diabetic patients only (group III) | 1.98 (0.97 - 5.25) | 0.1 - 1176.27 | ||||||||||||
Chronic kidney disease stage 1, 2 (group IV) | 1.27 (0.11 - 2.47) | 0 - 648.07 | ||||||||||||
Chronic kidney disease stage 3, 4 (group V) | 2.89 (0.23 - 5.46) | 0.01 - 49.18 | ||||||||||||
Post hoc analysis | ||||||||||||||
Group I vs group II | Group I vs group III | Group I vs group IV | Group I vs group V | Group II vs group III | Group II vs group IV | Group II vs group V | Group III vs group IV | Group III vs group V | Group IV vs group V | |||||
0.005 | 0.016 | 0.021 | 0.008 | 0.847 | 0.691 | 1.000 | 0.336 | 0.929 | 0.624 | |||||